SK286437B6 - Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie - Google Patents

Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie Download PDF

Info

Publication number
SK286437B6
SK286437B6 SK1543-99A SK154399A SK286437B6 SK 286437 B6 SK286437 B6 SK 286437B6 SK 154399 A SK154399 A SK 154399A SK 286437 B6 SK286437 B6 SK 286437B6
Authority
SK
Slovakia
Prior art keywords
composition
gel
alginate
protein
release
Prior art date
Application number
SK1543-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK154399A3 (en
Inventor
Merrill Seymour Goldenberg
Alice C. Beekman
Jian Hua Gu
Original Assignee
Amgen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen, Inc. filed Critical Amgen, Inc.
Publication of SK154399A3 publication Critical patent/SK154399A3/sk
Publication of SK286437B6 publication Critical patent/SK286437B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK1543-99A 1997-05-16 1998-05-18 Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie SK286437B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85797397A 1997-05-16 1997-05-16
US91290297A 1997-08-15 1997-08-15
PCT/US1998/010013 WO1998051348A2 (en) 1997-05-16 1998-05-18 Sustained-release delayed gels

Publications (2)

Publication Number Publication Date
SK154399A3 SK154399A3 (en) 2000-07-11
SK286437B6 true SK286437B6 (sk) 2008-10-07

Family

ID=27127437

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1543-99A SK286437B6 (sk) 1997-05-16 1998-05-18 Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie

Country Status (18)

Country Link
EP (1) EP0981374B1 (ja)
JP (1) JP2001525826A (ja)
KR (1) KR20010012374A (ja)
AU (1) AU7491898A (ja)
BG (1) BG64860B1 (ja)
BR (1) BR9809117A (ja)
CA (1) CA2289196C (ja)
CZ (1) CZ299180B6 (ja)
DE (1) DE69838750T2 (ja)
EA (1) EA199901013A1 (ja)
ES (1) ES2294814T3 (ja)
HU (1) HUP0003393A3 (ja)
IL (1) IL132814A0 (ja)
NO (1) NO995591D0 (ja)
PL (1) PL199565B1 (ja)
SK (1) SK286437B6 (ja)
WO (1) WO1998051348A2 (ja)
YU (1) YU58599A (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
CA2396431A1 (en) * 1999-11-29 2001-05-31 Advanced Research And Technology Institute, Inc. Sustained percutaneous delivery of a biologically active substance
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
EP1562546A1 (en) * 2002-10-25 2005-08-17 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
DK3081215T3 (da) * 2005-05-23 2020-04-27 Natural Alternatives Int Inc Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5107585B2 (ja) * 2007-01-29 2012-12-26 株式会社 メドレックス 低温充填ゼリー組成物とその製造方法
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
MX2015005839A (es) 2012-11-08 2015-12-17 Clearside Biomedical Inc Metodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
CN110302004B (zh) 2013-05-03 2023-04-28 科尼尔赛德生物医学公司 用于眼部注射的设备和方法
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
WO2017139375A1 (en) 2016-02-10 2017-08-17 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
EP3644729A1 (en) * 2018-06-04 2020-05-06 Spermvital AS Functionalized kit for preparing hydrogels
EP3878476A4 (en) * 2018-11-06 2022-07-27 National Cancer Center ALGINIC ACID INJECTABLE HYDROGEL SYSTEM
CN113423386A (zh) * 2019-10-01 2021-09-21 美国倍利年制药有限公司 治疗或预防肥胖和体重管理的方法
CN114533653B (zh) * 2020-11-26 2023-12-22 上海凯茂生物医药有限公司 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416979B2 (ja) * 1972-01-08 1979-06-26
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4789516A (en) * 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) * 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS645460A (en) * 1987-06-29 1989-01-10 Sanei Kagaku Kogyo Kk Production of delaying gelatinous material
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
IT1245383B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Composizione acquosa gelificabile avente tempo di gelificazione ritardato
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
KR960006730B1 (ko) * 1993-02-11 1996-05-23 재단법인한국화학연구소 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions

Also Published As

Publication number Publication date
ES2294814T3 (es) 2008-04-01
PL336887A1 (en) 2000-07-17
AU7491898A (en) 1998-12-08
NO995591L (no) 1999-11-15
SK154399A3 (en) 2000-07-11
DE69838750D1 (de) 2008-01-03
PL199565B1 (pl) 2008-10-31
HUP0003393A2 (hu) 2001-02-28
KR20010012374A (ko) 2001-02-15
NO995591D0 (no) 1999-11-15
HUP0003393A3 (en) 2001-03-28
CZ299180B6 (cs) 2008-05-14
EP0981374B1 (en) 2007-11-21
JP2001525826A (ja) 2001-12-11
EP0981374A2 (en) 2000-03-01
BR9809117A (pt) 2000-08-01
DE69838750T2 (de) 2008-10-30
EA199901013A1 (ru) 2000-06-26
YU58599A (sh) 2000-12-28
CA2289196C (en) 2007-08-07
WO1998051348A2 (en) 1998-11-19
BG103914A (en) 2000-07-31
IL132814A0 (en) 2001-03-19
BG64860B1 (bg) 2006-07-31
CA2289196A1 (en) 1998-11-19
CZ396399A3 (cs) 2000-04-12
WO1998051348A3 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
SK286437B6 (sk) Gélotvorná farmaceutická kompozícia s predĺženým uvoľňovaním a oneskorenou tvorbou gélu a jej použitie
US6656508B2 (en) Sustained-release alginate gels
US20010007673A1 (en) Sustained-release delayed gels
DE69933763T2 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
CA2433037C (en) Sustained-release preparation
JP5160005B2 (ja) 徐放性製剤
EP1335661A2 (en) Production of microspheres
US20100180464A1 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
AU2005200949B2 (en) Sustained-Release Delayed Gels
MXPA99010284A (en) Sustained-release delayed gels
CN1263472A (zh) 缓释延迟凝胶剂
KR100342746B1 (ko) 인슐린의 방출제어제제 및 그 방법
MXPA99009388A (en) Sustained-release alginate gels
JP2001151694A (ja) タンパク質粉体の製造法
CZ20004111A3 (cs) Biologicky odbouratelné alginátové gely s prodlouženým uvolňováním

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090518